共 50 条
- [1] Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States [J]. Journal of Experimental & Clinical Cancer Research, 42
- [5] FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients [J]. FRONTIERS IN ONCOLOGY, 2021, 11
- [8] Immune toxicity of checkpoint inhibitors: highlights [J]. REVUE DE MEDECINE INTERNE, 2021, 42 (10): : 10S19 - 10S22
- [9] Immune checkpoint inhibitors and cardiovascular toxicity [J]. LANCET ONCOLOGY, 2018, 19 (09): : E447 - E458
- [10] Conditional immune toxicity rate with immune checkpoint inhibitors [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7